SCHEMBL4939622

SCHEMBL4939622

Oc1cc(O)c(-c2nnc(O)n2-c2ccccc2Cl)c(Br)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 2/20 0.42
NOTUM Q6P988 2/20 0.34
HSD11B1 P28845 1/20 0.33
TLR8 Q9NR97 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
POLB P06746 1/20 0.32
GAA P10253 1/20 0.32
PKM P14618 1/20 0.32
BLM P54132 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HCAR1 Q9BXC0 1/20 0.32
CYP2D6 P10635 2/20 0.31
CYP2C19 P33261 2/20 0.31
NPSR1 Q6W5P4 2/20 0.31
CYP1A2 P05177 1/20 0.31
GLA P06280 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
APLNR P35414 1/20 0.31
PDE2A O00408 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4941528 0.79 HSP90AA1 (0.61) HSP90AA1NOTUMPDE2APDE10A
SCHEMBL930185 0.66 HSP90AA1 (0.58) HSP90AA1NOTUMPDE2APDE10A
SCHEMBL2640745 0.65 HSP90AA1 (0.40) HSP90AA1NOTUMTLR8POLBGAA
SCHEMBL4936289 0.65 HSP90AA1 (0.48) HSP90AA1NOTUMHSD11B1GAACYP2D6
SCHEMBL4939580 0.65 HSP90AA1 (0.58) HSP90AA1NOTUMHSD11B1POLBGAA
SCHEMBL4941855 0.64 PDE2A (0.42) HSP90AA1L3MBTL1POLBGAAPKM
SCHEMBL4941329 0.64 HSP90AA1 (0.62) HSP90AA1ALDH1A1HPGD
SCHEMBL4943270 0.63 HSP90AA1 (0.45) HSP90AA1ALDH1A1KDM4EMEN1KMT2A
SCHEMBL4939553 0.63 HSP90AA1 (0.70) HSP90AA1NOTUMHSD11B1GAASMN1; SMN2
SCHEMBL931818 0.60 HSP90AA1 (0.43) HSP90AA1CYP3A4ALDH1A1HPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US claimed
CN-101119978-A HSP90-inhibiting triazole derivatives MERCK PATENT GMBH (DE) 2008-02-06 CN claimed
EP-1853570-A2 HSP90-INHIBITING TRIAZOLE DERIVATIVES Merck Patent GmbH (DE) 2007-11-14 EP claimed
WO-2006087077-A2 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2006-08-24 WO claimed
US-8618285-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2013-12-31 US disclosed
EP-1853570-B1 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-10-24 EP disclosed
CN-101119978-B HSP 90-inhibiting triazole derivatives MERCK PATENT GMBH 2012-05-23 CN disclosed
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US disclosed
CN-101119978-A HSP90-inhibiting triazole derivatives MERCK PATENT GMBH (DE) 2008-02-06 CN disclosed
EP-1853570-A2 HSP90-INHIBITING TRIAZOLE DERIVATIVES Merck Patent GmbH (DE) 2007-11-14 EP disclosed
WO-2006087077-A2 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2006-08-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182857-A1 Triazole Derivatives HSP90AB1, HSP90AA1, HSP90B1 HSP90AA1 2/4885NOTUM 4417/4885HSD11B1 899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.